BJDX — Bluejay Diagnostics Cashflow Statement
0.000.00%
- $0.72m
- -$1.93m
Annual cashflow statement for Bluejay Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.82 | -1.16 | -3.49 | -9.3 | -9.95 |
Depreciation | |||||
Non-Cash Items | -0.835 | -0.104 | 0.461 | 0.82 | 0.325 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.178 | 0.596 | -1.49 | 0.579 | 0.667 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.69 | -0.509 | -4.37 | -7.74 | -8.31 |
Capital Expenditures | -0.006 | 0 | -0.024 | -1.2 | -0.704 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.006 | 0 | -0.024 | -1.2 | -0.704 |
Financing Cash Flow Items | 0.1 | 0 | -0.563 | -0.02 | -0.474 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.51 | 1.33 | 22.5 | 0.008 | 1.11 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.184 | 0.816 | 18.1 | -8.93 | -7.91 |